In addition to that, the percentage of CD34+ leukemic cells, CD34+CD38- leukemic cells and CD34+CD38low/−CD123+ cells were also significantly reduced in AML patients with CR than those with non-CR (P<0.001, P<0.004, P<0.001 respectively). This evidence concerns the gene CD38 and acute myeloid leukemia.